SFDA CEO: National Biotechnology Strategy Positions Saudi Arabia as Future Leader in Biomanufacturing and Medical Innovation
2024-09-14
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), Dr Hisham bin Saad Al-Jadhey, affirmed that the Kingdom of Saudi Arabia’s National Biotechnology Strategy places the Kingdom on track to become a global leader in biomanufacturing and medical innovation. The strategy prioritizes critical areas such as vaccines, biolocalization, genomics, and plant improvement.